According to the latest report by IMARC Group, titled "Regenerative Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on regenerative medicine market size. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global regenerative medicine market size reached US$ 18.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 61.4 Billion by 2028, exhibiting a growth rate (CAGR) of 22.4% during 2023-2028.
Regenerative medicine is a branch of biomedical science that involves replacing or restoring damaged tissues, organs, and cells. It also includes the utilization of laboratory-developed stem cells to implant into the body for regenerating damaged bones, blood vessels, cartilage, and organs that are impaired due to age, diseases and trauma. It deals with the repairing of injured joints and tissue that help in reducing inflammation and preventing scar tissue formation. Consequently, it is adopted in various clinical therapeutic procedures, including cell immunomodulation and tissue engineering therapies, and is extensively adopted for the treatment of numerous chronic diseases, such as Alzheimer’s, Parkinson’s, cardiovascular disorders (CVDs), cancer, osteoporosis, and spinal cord injuries.
Get a Free Sample Copy of this Report: https://www.imarcgroup.com/regenerative-medicine-market/requestsample
Market Trends:
The increasing prevalence of chronic disorders among the masses is driving the global market. Moreover, the growing demand for organ transplantation among patients and the commercialization of regenerative medicines are providing a thrust to the market. Furthermore, continual technological advancements in cell-based therapies, including the adoption of artificial intelligence (AI) in the production of regenerative medicines and the development of 3D bioprinting techniques, are acting as growth-inducing factors. In line with this, numerous leading players are focussing on extensive research and development (RD) activities to develop new technologies that offer better results in newly generated cells creating a positive market outlook. Other factors, including increasing government support and emerging healthcare infrastructure, are also influencing the market.
View Full Report with TOC List of Figure: https://www.imarcgroup.com/regenerative-medicine-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Allergan PLC (AbbVie Inc.)
- Amgen Inc.
- Baxter International Inc.
- BD (Becton, Dickinson and Company)
- Integra Lifesciences Holdings Corporation
- Medtronic plc
- Mimedx Group Inc.
- Novartis AG
- Osiris Therapeutics Inc. (Smith Nephew plc)
- Thermo Fisher Scientific Inc
Regenerative Medicine Market Segmentation:
Our report has categorized the market based on region, type, application and end user.
Breakup by Type:
- Stem Cell Therapy
- Biomaterial
- Tissue Engineering
- Others
Breakup by Application:
- Bone Graft Substitutes
- Osteoarticular Diseases
- Dermatology
- Cardiovascular
- Central Nervous System
- Others
Breakup by End User:
- Hospitals
- Specialty Clinics
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
